P. West-Thielke

发表

Meeting report: Consensus recommendations for a research agenda to address immunosuppressant nonadherence in organ transplantation

M. Dew, S. Heldenbrand, A. Maldonado, 2018, Clinical transplantation.

Clinical Pharmacologic Principles and Immunosuppression

B. Kaplan, P. West-Thielke, 2011 .

Obesity impacts acute rejection but not allograft function improvement in the setting of belatacept conversion

E. Benedetti, I. Tzvetanov, P. West-Thielke, 2021, Clinical transplantation.

Clinical Implications of Tacrolimus Time in Therapeutic Range and Intrapatient Variability in Urban Renal Transplant Recipients Undergoing Early Corticosteroid Withdrawal

E. Benedetti, Zahraa Hajjiri, I. Tzvetanov, 2021, Transplantation direct.

Cell Population in Spleens During Antibody-Mediated Rejection: Pathologic and Clinical Findings

S. Setty, E. Benedetti, J. Oberholzer, 2012, Transplantation.

Belatacept‐based immunosuppression with simultaneous calcineurin inhibitor avoidance and early corticosteroid withdrawal: A prospective, randomized multicenter trial

A. Matas, D. Kaufman, R. Alloway, 2020, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Living Donor Kidney Transplantation Across Positive Crossmatch: The University of Illinois at Chicago Experience

E. Benedetti, J. Oberholzer, B. Kaplan, 2009, Transplantation.

Evaluating the conversion to extended-release tacrolimus from immediate-release tacrolimus in liver transplant recipients

P. West-Thielke, David Choi, Sarang Thaker, 2021, European journal of gastroenterology & hepatology.

Transplant Pharmacists’ Experience With Telehealth During the COVID-19 Pandemic

D. Tsapepas, P. West-Thielke, Karen Khalil, 2022, Journal of pharmacy practice.

Results of Positive Cross‐Match Transplantation in African American Renal Transplant Recipients

E. Benedetti, J. Oberholzer, B. Kaplan, 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Clinical Utility of the OmniGraf Biomarker Panel in the Care of Kidney Transplant Recipients (CLARITY): Protocol for a Prospective, Multisite Observational Study

P. West-Thielke, J. Fleming, Y. Imamura, 2022, JMIR research protocols.

Results of ASERTAA, a Randomized Prospective Crossover Pharmacogenetic Study of Immediate-Release Versus Extended-Release Tacrolimus in African American Kidney Transplant Recipients.

D. Brennan, R. Bloom, R. Neubauer, 2018, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Safety and efficacy of eculizumab in the prevention of antibody‐mediated rejection in living‐donor kidney transplant recipients requiring desensitization therapy: A randomized trial

M. Stegall, G. Russ, R. Colvin, 2019, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Randomised controlled trial of a video intervention and behaviour contract to improve medication adherence after renal transplantation: the VECTOR study protocol

H. Mansell, R. Mainra, D. Blackburn, 2019, BMJ Open.

Belatacept for Simultaneous Calcineurin Inhibitor and Chronic Corticosteroid Immunosuppression Avoidance

D. Kaufman, R. Alloway, E. Woodle, 2021, Clinical journal of the American Society of Nephrology : CJASN.

Eculizumab for Prevention of Antibody-Mediated Rejection in Blood Group-Incompatible Renal Transplantation.

E. Benedetti, N. Jasiak, L. Gallon, 2018, Transplantation proceedings.

Conversion From Twice-Daily Tacrolimus to Once-Daily Extended Release Tacrolimus (LCPT): The Phase III Randomized MELT Trial

S. Mulgaonkar, K. Budde, L. Rostaing, 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

LCPT once‐daily extended‐release tacrolimus tablets versus twice‐daily capsules: a pooled analysis of two phase 3 trials in important de novo and stable kidney transplant recipient subgroups

S. Mulgaonkar, K. Budde, L. Rostaing, 2016, Transplant international : official journal of the European Society for Organ Transplantation.

Switching STudy of Kidney TRansplant PAtients with Tremor to LCP‐TacrO (STRATO): an open‐label, multicenter, prospective phase 3b study

K. Sethi, J. Morgan, A. Matas, 2015, Clinical transplantation.

Reported Isolated Pancreas Rejection Is Associated With Poor Kidney Outcomes in Recipients of a Simultaneous Pancreas Kidney Transplant

G. Knoll, E. Benedetti, J. Oberholzer, 2008, Transplantation.

Combined Robot-assisted Kidney Transplantation and Sleeve Gastrectomy in a Morbidly Obese Recipient

E. Benedetti, J. Oberholzer, P. Giulianotti, 2015, Transplantation.

Advances in personalized medicine and noninvasive diagnostics in solid organ transplantation

A. Maldonado, P. West-Thielke, C. Marks, 2020, Pharmacotherapy.

A novel and personalized rehabilitation program for obese kidney transplant recipients.

B. Fernhall, E. Benedetti, J. Oberholzer, 2014, Transplantation proceedings.

Evaluation of Flexible Tacrolimus Drug Concentration Monitoring Approach in Patients Receiving Extended‐Release Once‐Daily Tacrolimus Tablets

B. Philosophe, N. Leca, P. West-Thielke, 2018, Journal of clinical pharmacology.

Experimental protocol of a randomized controlled clinical trial investigating the effects of personalized exercise rehabilitation on kidney transplant recipients' outcomes.

B. Fernhall, E. Benedetti, L. Gallon, 2015, Contemporary clinical trials.

Therapeutic Monitoring of Mycophenolic Acid: Is There Clinical Utility?

B. Kaplan, P. West-Thielke, 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

A randomized, open‐label pharmacokinetic trial of tacrolimus extended‐release dosing in obese de novo kidney transplant recipients

S. Patel, E. Benedetti, E. Wenzler, 2019, Clinical transplantation.

ABO incompatible renal transplantation in an HIV-seropositive patient.

E. Benedetti, J. Oberholzer, B. Kaplan, 2008, Transplantation.

Removal of Anti-Thymocyte Globulin by Plasma Exchange in ABO-Incompatible and Positive Crossmatch Kidney Transplant Recipients.

E. Benedetti, B. Kaplan, Heather J. Ipema, 2021, Transplantation proceedings.

Results of ASERTAA, a Randomized Prospective Crossover Pharmacogenetic Study of Immediate-Release Versus Extended-Release Tacrolimus in African American Kidney Transplant Recipients.

D. Brennan, R. Bloom, R. Neubauer, 2018, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Evaluation of prior authorizations in transplant recipients at an urban institution

Ruchik Patel, P. West-Thielke, David Choi, 2023, Clinical transplantation.